Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling

Journal of Cell Science

Volumn 128, Issue 21, 2015, Pages 3878-3887

  O'Sullivan, Catherine ^a   Dev, Kumlesh K ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Astrocytes; Demyelination; Krabbe disease; PFTY720; Sphingosine 1 phosphate receptors

Indexed keywords

FINGOLIMOD; GALACTOSYLCERAMIDASE; PSYCHOSINE; SPHINGOSINE 1 PHOSPHATE; LIPOPOLYSACCHARIDE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL SURVIVAL; CEREBELLAR SLICE; CYTOKINE RESPONSE; GLOBOID CELL LEUKODYSTROPHY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DEMYELINATING DISEASES; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; LEUKODYSTROPHY, GLOBOID CELL; METABOLISM;

ANIMALS; APOPTOSIS; ASTROCYTES; DEMYELINATING DISEASES; FINGOLIMOD HYDROCHLORIDE; HUMANS; LEUKODYSTROPHY, GLOBOID CELL; LIPOPOLYSACCHARIDES; LYSOPHOSPHOLIPIDS; MICE; MICROSCOPY, FLUORESCENCE; PSYCHOSINE; RATS; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84946097393     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.169342     Document Type: Article

References (53)

1. Adachi, K. and Chiba, K. (2008). FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology. Perspect. Med. Chem. 1, 11-23.
2. Asle-Rousta, M., Kolahdooz, Z., Oryan, S., Ahmadiani, A. and Dargahi, L. (2013). FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-induced impairment of spatial learning and memory in rats. J. Mol. Neurosci. 50, 524-532.
3. Balatoni, B., Storch, M. K., Swoboda, E.-M., Schönborn, V., Koziel, A., Lambrou, G. N., Hiestand, P. C., Weissert, R. and Foster, C. A. (2007). FTY720 sustains and restores neuronal function in the DA rat model of MOGinduced experimental autoimmune encephalomyelitis. Brain Res. Bull. 74, 307-316.
4. Cantuti-Castelvetri, L., Zhu, H., Givogri, M. I., Chidavaenzi, R. L., Lopez-Rosas, A. and Bongarzone, E. R. (2012). Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases. Neurobiol. Dis. 46, 325-335.
5. Castelvetri, L. C., Givogri, M. I., Zhu, H., Smith, B., Lopez-Rosas, A., Qiu, X., van Breemen, R. and Bongarzone, E. R. (2011). Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 122, 35-48.
6. Choi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C.-W., Noguchi, K., Teo, S. T., Yung, Y. C., Lu, M., Kennedy, G. et al. (2011). FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl. Acad. Sci. USA 108, 751-756.
7. Claycomb, K., Johnson, K., Winokur, P., Sacino, A. and Crocker, S. (2013). Astrocyte regulation of CNS inflammation and remyelination. Brain Sci. 3, 1109-1127.
8. Coelho, R. P., Payne, S. G., Bittman, R., Spiegel, S. and Sato-Bigbee, C. (2007). The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J. Pharmacol. Exp. Ther. 323, 626-635.
9. Cooper, C. E., Markus, M., Seetulsingh, S. P. and Wrigglesworth, J. M. (1993). Kinetics of inhibition of purified and mitochondrial cytochrome c oxidase by psychosine (beta-galactosylsphingosine). Biochem. J. 290, 139-144.
10. Davenport, A., Williamson, P. and Taylor, R. (2011). Pathophysiology of Krabbe disease. Orbit 2, 1-20.
11. Deogracias, R., Yazdani, M., Dekkers, M. P. J., Guy, J., Ionescu, M. C. S., Vogt, K. E. and Barde, Y.-A. (2012). Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 109, 14230-14235.
12. Dev, K. K., Mullershausen, F., Mattes, H., Kuhn, R. R., Bilbe, G., Hoyer, D. and Mir, A. (2008). Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol. Ther. 117, 77-93.
13. di Penta, A., Moreno, B., Reix, S., Fernandez-Diez, B., Villanueva, M., Errea, O., Escala, N., Vandenbroeck, K., Comella, J. X. and Villoslada, P. (2013). Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS ONE 8, e54722.
14. Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C. and Pouly, S. (2011). Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE 6, e23905.
15. Fyrst, H. and Saba, J. D. (2010). An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat. Chem. Biol. 6, 489-497.
16. Giri, S., Jatana, M., Rattan, R., Won, J.-S., Singh, I. and Singh, A. K. (2002). Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J. 16, 661-672.
17. Giri, S., Khan, M., Rattan, R., Singh, I. and Singh, A. K. (2006). Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J. Lipid Res. 47, 1478-1492.
18. Giri, S., Khan, M., Nath, N., Singh, I. and Singh, A. K. (2008). The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J. Neurochem. 105, 1820-1833.
19. Hannun, Y. A. and Bell, R. M. (1987). Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235, 670-674.
20. Haq, E., Giri, S., Singh, I. and Singh, A. K. (2003). Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J. Neurochem. 86, 1428-1440.
21. Healy, L. M., Sheridan, G. K., Pritchard, A. J., Rutkowska, A., Mullershausen, F. and Dev, K. K. (2013). Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes. Br. J. Pharmacol. 169, 1114-1129.
22. Jatana, M., Giri, S. and Singh, A. K. (2002). Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci. Lett. 330, 183-187.
23. Jung, C. G., Kim, H. J., Miron, V. E., Cook, S., Kennedy, T. E., Foster, C. A., Antel, J. P. and Soliven, B. (2007). Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 55, 1656-1667.
24. Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L. et al. (2010). A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387-401.
25. Kim, H. J., Miron, V. E., Dukala, D., Proia, R. L., Ludwin, S. K., Traka, M., Antel, J. P. and Soliven, B. (2011). Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. FASEB J. 25, 1509-1518.
26. Kondo, Y., Wenger, D. A., Gallo, V. and Duncan, I. D. (2005). Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc. Natl. Acad. Sci. USA 102, 18670-18675.
27. Lee, K. D., Chow, W. N., Sato-Bigbee, C., Graf, M. R., Graham, R. S., Colello, R. J., Young, H. F. and Mathern, B. E. (2009). FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J. Neurotrauma 26, 2335-2344.
28. LeVine, S. M. and Brown, D. C. (1997). IL-6 and TNFa expression in brains of twitcher, quaking and normal mice. J. Neuroimmunol. 73, 47-56.
29. Mattes, H., Dev, K. K., Bouhelal, R., Barske, C., Gasparini, F., Guerini, D., Mir, A. K., Orain, D., Osinde, M., Picard, A. et al. (2010). Design and synthesis of selective and potent orally active S1P5 agonists. ChemMedChem 5, 1693-1696.
30. Miron, V. E., Hall, J. A., Kennedy, T. E., Soliven, B. and Antel, J. P. (2008a). Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod. Am. J. Pathol. 173, 1143-1152.
31. Miron, V. E., Jung, C. G., Kim, H. J., Kennedy, T. E., Soliven, B. and Antel, J. P. (2008b). FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann. Neurol. 63, 61-71.
32. Miron, V. E., Ludwin, S. K., Darlington, P. J., Jarjour, A. A., Soliven, B., Kennedy, T. E. and Antel, J. P. (2010). Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am. J. Pathol. 176, 2682-2694.
33. Mullershausen, F., Craveiro, L. M., Shin, Y., Cortes-Cros, M., Bassilana, F., Osinde, M., Wishart, W. L., Guerini, D., Thallmair, M., Schwab, M. E. et al. (2007). Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J. Neurochem. 102, 1151-1161.
34. Mullershausen, F., Zecri, F., Cetin, C., Billich, A., Guerini, D. and Seuwen, K. (2009). Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nat. Chem. Biol. 5, 428-434.
35. Orfi, L., Larive, C. K. and LeVine, S. M. (1997). Physicochemical characterization of psychosine by 1H nuclear magnetic resonance and electron microscopy. Lipids 32, 1035-1040.
36. Osinde, M., Mullershausen, F. and Dev, K. K. (2007). Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 52, 1210-1218.
37. Pritchard, A. J., Mir, A. K. and Dev, K. K. (2014). Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures. PLoS ONE 9, e99444.
38. Rutkowska, A., Preuss, I., Gessier, F., Sailer, A. W. and Dev, K. K. (2015). EBI2 regulates intracellular signaling and migration in human astrocyte. Glia 63, 341-351.
39. Sharma, R., Fischer, M.-T., Bauer, J., Felts, P. A., Smith, K. J., Misu, T., Fujihara, K., Bradl, M. and Lassmann, H. (2010). Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol. 120, 223-236.
40. Sheridan, G. K. and Dev, K. K. (2012). S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia 60, 382-392.
41. Sugama, S., Kim, S. U., Ida, H. and Eto, Y. (1990). Psychosine cytotoxicity in rat neural cell cultures and protection by phorbol ester and dimethyl sulfoxide. Pediatr. Res. 28, 473-476.
42. Suzuki, K. (1998). Twenty five years of the 'Psychosine Hypothesis': a personal perspective of its history and present status. Neurochem. Res. 23, 251-259.
43. Suzuki, K. (2003). Globoid cell leukodystrophy (Krabbe's disease): update. J. Child Neurol. 18, 595-603.
44. Svennerholm, L., Vanier, M. T. and Månsson, J. E. (1980). Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J. Lipid Res. 21, 53-64.
45. Tapasi, S., Padma, P. and Setty, O. H. (1998). Effect of psychosine on mitochondrial function. Indian J. Biochem. Biophys. 35, 161-165.
46. Tohyama, J., Matsuda, J. and Suzuki, K. (2001). Psychosine is as potent an inducer of cell death as C6-ceramide in cultured fibroblasts and in MOCH-1 cells. Neurochem. Res. 26, 667-671.
47. Wang, W., Huang, M.-C. and Goetzl, E. J. (2007). Type 1 sphingosine 1-phosphate G protein-coupled receptor (S1P1) mediation of enhanced IL-4 generation by CD4T cells from S1P1 transgenic mice. J. Immunol. 178, 4885-4890.
48. Wenger, D. A., Rafi, M. A. and Luzi, P. (1997). Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum. Mutat. 10, 268-279.
49. Wenger, D. A., Suzuki, K., Suzuki, Y. and Suzuki, K. (2001). Galactosylceramide Lipidosis: Globoid Cell Leukodystrophy (Krabbe Disease), pp. 3669-3694. New York. McGraw-Hill.
50. White, A. B., Galbiati, F., Givogri, M. I., Lopez rosas, A., Qiu, X., Van breemen, R. and Bongarzone, E. R. (2011). Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease. J. Neurosci. Res. 89, 352-364.
51. Yamada, H., Martin, P. and Suzuki, K. (1996). Impairment of protein kinase C activity in twitcher Schwann cells in vitro. Brain Res. 718, 138-144.
52. Zaka, M. and Wenger, D. A. (2004). Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation. Neurosci. Lett. 358, 205-209.
53. Zhang, Z., Fauser, U. and Schluesener, H. J. (2008). Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury. Neuropathol. Appl. Neurobiol. 34, 330-339.